Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: A comparison with previously known prognostic models

被引：0
|
作者：
Baek, K.
Kim, J.
Um, J.
Park, S.
Lee, J.
Park, J.
Park, Y.
Lim, H.
Kang, W.
机构：
[1] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.323
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
323
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PROGNOSTIC FACTORS IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB: A RETROSPECTIVE COMPARISON WITH PREVIOUSLY KNOWN PROGNOSTIC MODELS
    Baek, K. K.
    Kim, J.
    Kim, J. E.
    Park, S. H.
    Lee, J. Y.
    Park, J. O.
    Park, Y. S.
    Lim, H. Y.
    Kang, W. K.
    ANNALS OF ONCOLOGY, 2010, 21 : 259 - 259
  • [2] Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Retrospective Comparison with Previously Known Prognostic Models
    Baek, Kyung Kee
    Kim, Jung-Hoon
    Uhm, Ji Eun
    Park, Se Hoon
    Lee, Jeeyun
    Park, Joon Oh
    Park, Young Suk
    Kang, Won Ki
    Lim, Ho Yeong
    ONCOLOGY, 2011, 80 (3-4) : 167 - 174
  • [3] Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
    Pinter, M.
    Sieghart, W.
    Hucke, F.
    Graziadei, I.
    Vogel, W.
    Maieron, A.
    Koenigsberg, R.
    Weissmann, A.
    Kornek, G.
    Matejka, J.
    Stauber, R.
    Buder, R.
    Gruenberger, B.
    Schoeniger-Hekele, M.
    Mueller, C.
    Peck-Radosavljevic, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 949 - 959
  • [4] Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib
    Sansone, Vito
    Tovoli, Francesco
    Casadei-Gardini, Andrea
    Di Costanzo, Giovan Giuseppe
    Magini, Giulia
    Sacco, Rodolfo
    Pressiani, Tiziana
    Trevisani, Franco
    Rimini, Margherita
    Tortora, Raffaella
    Nardi, Elena
    Ielasi, Luca
    Piscaglia, Fabio
    Granito, Alessandro
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (01)
  • [5] Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
    Labeur, Tim A.
    Berhane, Sarah
    Edeline, Julien
    Blanc, Jean-Frederic
    Bettinger, Dominik
    Meyer, Tim
    Van Vugt, Jeroen L. A.
    Ten Cate, David W. G.
    De Man, Robert A.
    Eskens, Ferry A. L. M.
    Cucchetti, Alessandro
    Bonnett, Laura J.
    Van Delden, Otto M.
    Klumpen, Heinz-Josef
    Takkenberg, R. Bart
    Johnson, Philip J.
    LIVER INTERNATIONAL, 2020, 40 (01) : 215 - 228
  • [6] IMPROVED SURVIVAL PREDICTION AND COMPARISON OF PROGNOSTIC MODELS FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
    Labeur, Tim
    Berhane, Sarah
    Edeline, Julien
    Blanc, Jean-Frederic
    Bettinger, Dominik
    Meyer, Timothy
    van Vugt, Jeroen
    Ten Cate, David
    De Man, Robert A.
    Eskens, Ferry
    Cucchetti, Alessandro
    Van Delden, Otto
    Klumpen, Heinz-Josef
    Takkenberg, Robert Bart
    Johnson, Philip
    HEPATOLOGY, 2019, 70 : 525A - 526A
  • [7] Prognostic impact of pERK in advanced hepatocellular carcinoma patients treated with sorafenib
    Chen, D.
    Zhao, P.
    Li, S. -Q.
    Xiao, W. -K.
    Yin, X. -Y.
    Peng, B. -G.
    Liang, L. -J.
    EJSO, 2013, 39 (09): : 974 - 980
  • [8] Efficacy of Sorafenib for Advanced Hepatocellular Carcinoma and Prognostic Factors
    Li, Jinpeng
    Wang, Lijun
    Cong, Ning
    Shi, Congcong
    Bu, Wenzhe
    Song, Jinlong
    Chen, Hua
    HEPATO-GASTROENTEROLOGY, 2014, 61 (132) : 954 - 957
  • [9] A multicenter analysis of prognostic factors in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib.
    Smith, Alan D.
    Chan, Kelvin K.
    Lim, Howard John
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
    Marasco, Giovanni
    Colecchia, Antonio
    Reggiani, Maria Letizia Bacchi
    Celsa, Ciro
    Farinati, Fabio
    Giannini, Edoardo Giovanni
    Benevento, Francesca
    Rapaccini, Gian Ludovico
    Caturelli, Eugenio
    Di Marco, Mariella
    Biasini, Elisabetta
    Marra, Fabio
    Morisco, Filomena
    Foschi, Francesco Giuseppe
    Zoli, Marco
    Gasbarrini, Antonio
    Baroni, Gianluca Svegliati
    Masotto, Alberto
    Sacco, Rodolfo
    Raimondo, Giovanni
    Azzaroli, Francesco
    Mega, Andrea
    Vidili, Gianpaolo
    Brunetto, Maurizia Rossana
    Nardone, Gerardo
    Dajti, Elton
    Ravaioli, Federico
    Avanzato, Francesca
    Festi, Davide
    Trevisani, Franco
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (08) : 1011 - 1019
12345